Menu
Begin main content
Home Search
Result Type
Evidence Bundles
Product Line
Body Systems
Disease and Conditions
Target Population
Technologies, Therapies and Systems
Testing and Diagnostics
Publication Date
Clear all filters

Reports

We found 5919 result(s)

dupilumab (Dupixent)

Last Updated: February 13, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: dupilumab
Indications: atopic dermatitis

  • Brand Name: Dupixent
  • Manufacturer: Sanofi Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0636-000
  • Project Status: Active
  • Submission Type: New
Details

esketamine hydrochloride (TBC )

Last Updated: February 26, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: esketamine hydrochloride
Indications: Major depressive disorder (MDD), adults

  • Brand Name: TBC
  • Manufacturer: Janssen Inc.
  • Project Number: SR0621-000
  • Project Status: Active
  • Submission Type: New
Details

budesonide (Jorveza)

Last Updated: February 21, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: budesonide
Indications: Eosinophilic esophagitis, adults

  • Brand Name: Jorveza
  • Manufacturer: AVIR Pharma Inc.
  • Project Number: SR0634-000
  • Project Status: Active
  • Submission Type: New
Details

ixekizumab (Taltz )

Last Updated: February 25, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ixekizumab
Indications: Ankylosing spondylitis

  • Brand Name: Taltz
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0630-000
  • Project Status: Active
  • Submission Type: New Indication
Details

ustekinumab (Stelara/Stelara I.V)

Last Updated: February 20, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ustekinumab
Indications: Ulcerative colitis

  • Brand Name: Stelara/Stelara I.V
  • Manufacturer: Janssen Inc.
  • Project Number: SR0627-000
  • Project Status: Active
  • Submission Type: New Indication
Details

Iron (III) Isomaltoside 1000 (Monoferric)

Last Updated: February 26, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Iron (III) Isomaltoside 1000
Indications: iron deficiency anemia

  • Brand Name: Monoferric
  • Manufacturer: Pharmacosmos A/S
  • Project Number: SR0622-000
  • Project Status: Active
  • Submission Type: New
Details

burosumab (Crysvita)

Last Updated: November 28, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: burosumab
Indications: Treatment of X-Linked Hypophosphatemia

  • Brand Name: Crysvita
  • Manufacturer: Kyowa Kirin Limited
  • Project Number: SR0602-000
  • Project Status: Active
  • Submission Type: New
Details

vortioxetine hydrobromide (Trintellix )

Last Updated: February 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: vortioxetine hydrobromide
Indications: Major depressive disorder (MDD), adults.

  • Brand Name: Trintellix
  • Manufacturer: Lundbeck Canada Inc.
  • Project Number: SR0611-000
  • Project Status: Active
  • Submission Type: New
Details

glycopyrrolate (Cuvposa)

Last Updated: February 10, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: glycopyrrolate
Indications: chronic severe drooling, neurologic (pediatric)

  • Brand Name: Cuvposa
  • Manufacturer: MEDEXUS Pharmaceuticals, Inc.
  • Project Number: SR0613-000
  • Project Status: Active
  • Submission Type: New
Details

belimumab (Benlysta )

Last Updated: February 10, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Belimumab
Indications: systemic lupus erythematosus

  • Brand Name: Benlysta
  • Manufacturer: GlaxoSmithKline Inc.
  • Project Number: SR0616-000
  • Project Status: Active
  • Submission Type: New
Details